Skip to content
If you’re a mobile developer who monetises health‑related apps, the new Google AdMob pharmaceutical rules landing in January 2026 could be a game‑changer – for better or worse. From unlocking high‑CPM prescription‑drug ads in the U.S., Canada and New Zealand to tightening bans on “miracle cures” worldwide, the policy revamp reshapes every ad you serve.
In the next few minutes you’ll discover exactly what’s allowed, how to configure granular filters, and the checklist you need to keep your account safe while cashing in on the newly‑permitted inventory.
Table of Contents
1. Why This Update Matters
If you monetize a health‑related app, a wellness portal, or even a generic lifestyle app that shows content about medicines, you’ve probably already been wrestling with Google’s “Pharmaceuticals” rules. Starting January 2026, Google is tightening and reorganising those rules for Authorized Buyers on the AdMob network.
Key takeaways:
- Policy name change: “Pharmaceutical product policy” → “Pharmaceutical products and services policy.”
- Policy language is rewritten for clarity – meaning the same rules, but now they’re easier (and harder) to interpret.
- Authorized Buyers no longer need Google certification to promote prescription‑drug content provided they stay within the new location‑based restrictions.
- AdMob publishers gain more granular control – you can now block or allow specific sub‑categories (e.g., OTC vs. prescription‑drug terms) directly from the UI.
In short: more opportunity for advertisers, more responsibility for you.
Also Read: Google Search adds a “Plus” menu for image & file uploads – AI Mode integration
2. What’s Changing? – The New “Pharmaceutical Products & Services” Policy
Below is the distilled version of the official policy (the full wording lives in Google’s policy centre).
| Section | Summary |
|---|---|
| Scope | Applies to all ads on Google Partner Inventory (AdMob, Ad Manager, etc.) that promote: • Prescription drugs • Online pharmacies • Unapproved pharmaceuticals & supplements • Illegal drugs & paraphernalia • Certain medical services (e.g., clinical trials, fertility products, “miracle cures”) |
| Disapproved content | Absolute bans (no exceptions) on the categories listed in the “Disallowed” column (see Section 3). |
| Allowed with restrictions | OTC drugs and prescription‑drug terminology can run if they meet location‑specific rules and all local legal requirements. No Google‑level certification is required. |
| Creative requirements | Certain locales (e.g., South Korea) demand an Ad Deliberation Number displayed in the creative with a minimum font size of 8pt. Missing or malformed numbers → disapproval. |
The policy now separates “Disapproved content” from “Content allowed with restrictions,” making it far clearer which ad types you can safely whitelist in your app.
3. Disallowed Content – What Gets Blocked Immediately
Any ad that falls into the following buckets will be rejected on AdMob, regardless of geography:
| Category | Examples |
|---|---|
| Clinical & reproductive health | Clinical‑trial recruitment, contraception ads, fertility tests, “miracle cure” claims, HIV home‑test kits, misleading health claims |
| Unapproved pharmaceuticals & supplements | Products not cleared by the FDA/EU/Health Canada, “dietary supplements” that claim to treat disease |
| Illegal drugs & paraphernalia | Bongs, glass pipes, hookahs, pill presses, drug‑testing evasion tools, herbal psychedelics |
| Recovery‑oriented addiction services | Directories for addiction treatment, sober‑living referral services, crisis hotlines (unless they are purely informational public‑service announcements) |
| Speculative & experimental treatments | Stem‑cell therapy, gene‑editing kits, DIY bio‑hacking, platelet‑rich plasma, regenerative‑medicine claims |
Why it matters: If a single disallowed ad appears in your app, Google may suspend the ad unit or terminate your AdMob account after repeated violations.
4. Allowed Content – The “With Restrictions” Zone
4.1 Over‑the‑Counter (OTC) Drugs
| Condition | Details |
|---|---|
| Geography | Allowed everywhere except China, Russia, and Brazil (local restrictions). |
| Creative requirement | In South Korea, the ad must include the Ad Deliberation Number – a string of digits issued by the Korean Ministry of Health – displayed somewhere in the creative with a font size ≥ 8 pt. |
| Compliance | Must adhere to local advertising law (e.g., no false efficacy claims, mandatory safety warnings). |
| What you can block | In the AdMob UI you can now create a category filter called “OTC Drugs” and toggle it on/off per app. It’s recommended to keep it on unless you have verified that all served ads are compliant. |
4.2 Prescription‑Drug Terms (Restricted Drug Terms)
| Region | What’s permitted |
|---|---|
| United States, Canada, New Zealand | Full promotional use of prescription‑drug names, active‑ingredient terms, brand names, and calls‑to‑action (e.g., “Buy Xyz Drug”). |
| All other regions | No promotional use of prescription‑drug terms. However, non‑promotional use is allowed (e.g., academic articles, public‑health warnings, regulatory disclosures). |
| Special notes | • If you run an app that serves global traffic, you’ll need location‑based ad filtering (see Section 6). • Google’s “Restricted Drug Terms” list is non‑exhaustive; new drugs may be added without notice, so stay updated via the policy dashboard. |
Also Read: Google Updates JavaScript SEO Docs – How to Keep Canonicals Consistent Before & After Rendering
5. How This Affects Your AdMob Revenue
| Scenario | Impact on eCPM | Action Required |
|---|---|---|
| You currently block the whole “Pharmaceuticals” category | May lose high‑value prescription‑drug spend in the US/CA/NZ. | Consider unblocking only the “Prescription‑drug terms” sub‑category for those regions. |
| Your app is health‑focused and gets many OTC queries | Potential lift of 10‑20 % in CPM where OTC ads are permitted. | Ensure you don’t block “OTC Drugs” in allowed markets. |
| You have users from China, Russia, Brazil | No OTC revenue, but you could still earn from non‑pharma ads. | Keep OTC block ON for those geos. |
| You serve a global audience with mixed health content | Complexity increases; risk of accidental disallowed ads. | Deploy geo‑targeted filters (see Section 6) and set up policy‑violation alerts in the AdMob console. |
Bottom line: Strategic unblocking can boost CPM, but mis‑blocking can crash your account. Use the granular controls introduced with this update.
6. Step‑by‑Step: Configuring AdMob to Stay Compliant
- Log into the AdMob console → Apps → select the app you want to edit.
- Click “Ad Settings” → “Category Blocking.”
- You’ll now see a new top‑level category called “Pharmaceutical products and services.” Click the arrow to expand it.You’ll see three sub‑categories:
- OTC Drugs
- Prescription‑drug terms (Restricted Drug Terms)
- All other pharmaceutical content (which includes the disallowed items listed in Section 3)
- Apply geo‑filters:
- Click the “Location Settings” icon next to each sub‑category.
- Add Allowed or Blocked regions.
- Example:Sub‑categoryAllowed RegionsBlocked RegionsOTC DrugsWorldwide except China, Russia, BrazilChina, Russia, BrazilPrescription‑drug termsUnited States, Canada, New ZealandAll other countriesDisallowed pharmaAll (default)—
- Save changes and publish. Changes propagate to the ad server within ~15 minutes.
- Activate “Policy Violation Alerts”:
- In AdMob → Policy Center → Alerts, toggle “Email me on policy violations”.
- This gives you a 24‑hour buffer to correct any disallowed ad that slips through.
- Test with the “Ad Preview” tool (found under Ad Sources > Test Ads) by selecting the target country; verify that the correct ad types appear.
Tip: If you have multiple app versions (e.g., a free vs. premium version), set up separate ad units for each and apply the filters per unit. This prevents a “one‑size‑fits‑all” mistake.
7. Best‑Practice Checklist for Developers
| ✅ Item | Description |
|---|---|
| 1️⃣ Review existing ad units | Identify any that currently block the entire “Pharmaceuticals” category. |
| 2️⃣ Map your user geography | Use Firebase Analytics to see the top 5 countries by MAU. Prioritise those in the filter matrix. |
| 3️⃣ Update ad‑creative compliance | If you serve Korean users, embed the Ad Deliberation Number (≥8 pt) in any OTC creative. |
| 4️⃣ Create a “pharma‑policy” SOP | Document steps to audit disallowed ad IDs (via the “Ad Review” report) and a 48‑hour remediation plan. |
| 5️⃣ Test before launch | Use the Ad Preview tool for each region you allow. |
| 6️⃣ Set up automated alerts | Enable email + Slack webhook for policy violations. |
| 7️⃣ Keep the policy feed refreshed | Subscribe to the Google Ads Policy Updates RSS feed; policy changes happen quarterly. |
| 8️⃣ Educate your team | Run a 15‑minute “Pharma Policy 101” for your ad‑ops and product managers. |
| 9️⃣ Consider “SafeHouse” fallback | If you’re unsure about an ad, enable the “General SafeHouse” ad source that only serves generic, non‑pharma ads. |
| 🔟 Document everything | Retain screenshots of your filter configuration in a version‑controlled repository (e.g., Git). |
8. Frequently Asked Questions
Do I need to get a Google certification to serve prescription‑drug ads?
No. Starting Jan 2026, Authorized Buyers can run such ads without a Google certificate—provided they follow the location‑based restrictions.
What if I inadvertently serve a disallowed ad in a restricted country?
You’ll receive a policy‑violation alert. Remove the offending ad unit or adjust your filters within 24 hours to avoid account suspension.
Can I block only “miracle‑cure” ads while allowing legitimate OTC drugs?
Yes. The new UI lets you block the “All other pharmaceutical content” sub‑category while keeping OTC Drugs enabled for allowed locations.
How do I know whether a drug is “OTC” or “prescription” in a given country?
Consult the national drug‑regulatory agency (e.g., FDA, Health Canada, EMA). Google does not provide a definitive list; you are responsible for compliance.
Will the new policy affect AdMob mediation partners?
Mediation partners (e.g., Unity Ads, IronSource) must also comply with Google’s policy. However, you can still mediate with them as long as the final ad that wins the auction respects the AdMob filters you set.
Are there any new reporting metrics for pharma ads?
Not yet. The existing Policy Center reports will flag any disallowed pharma ads. Watch for future “Pharma‑specific” dashboards in Q2 2026.
Is there a grace period for existing ads that might violate the new rules?
No formal grace period. Google will begin enforcing the updated policy on 1 January 2026.
9. What to Watch for After January 2026
- Emerging “Hybrid” products – Companies blending supplements with drug‑like claims (e.g., “CBD‑enhanced pain relief”) will be scrutinised. Expect stricter enforcement.
- Local law updates – Some countries (e.g., India, Mexico) are revising OTC classification; keep legal counsel in the loop.
- Creative‑format changes – If you use native ads, remember that the Ad Deliberation Number must be visible in any format (native, banner, interstitial).
- Policy‑violation rate dashboards – Google may introduce a “Pharma‑Compliance Score” in AdMob’s Policy Center. Aim for 100 % to avoid revenue throttling.
10. Final Thoughts
The January 2026 Google AdMob pharmaceutical update is a double‑edged sword: it unlocks new, high‑value ad inventory for eligible markets while raising the compliance bar across the board.
If you’re a health‑app developer, now is the moment to audit your ad filters, tighten your geo‑targeting, and embed the mandatory compliance elements.
By following the step‑by‑step configuration guide and the checklist above, you can protect your account, maintain revenue stability, and potentially capture higher CPMs from legitimate pharmaceutical advertisers.
Pro tip: Keep a monthly compliance audit on your calendar (e.g., first Monday of each month). A quick 15‑minute review of the Policy Center and filter settings can save you from a costly suspension later in the year.
Stay compliant, stay profitable, and happy monetising!
Reference: Google Ads Policy Center – Pharmaceutical products and services (updated Jan 2026)
If you found this article useful, consider sharing it with fellow developers or subscribing to our newsletter for the latest AdMob policy insights.
